Come up with a name for your new list and we'll add to it:
Recensa Therapeutics raised a round of funding on June 13, 2017. Investors include
Phase 1 Ventures.
Recensa Therapeutics screens for molecules that stimulate the body's anti-oxidant response against inflammation. Recensa is using this technology to develop topical therapies for the treatment of psor…